Resumen

ACHE, Yamel; GUAMAN, Carlos  y  RAMOS, María Victoria. The best of the 2020 European Society of Cardiology Congress: the digital experience. Rev.Urug.Cardiol. [online]. 2020, vol.35, n.3, pp.133-172.  Epub 01-Dic-2020. ISSN 0797-0048.  https://doi.org/10.29277/cardio.35.3.11.

The need for social distancing imposed by the current coronavirus pandemic, forced the different scientific societies to carry out their activities in a completely virtual format. And the European Society of Cardiology has not been the exception. From August 29 to September 1 of 2020, this unprecedented event was held which, in addition to having 125,000 health professionals from 213 countries, allowed free access to all netizens. In this way, current affairs in cardiology could reach all corners of the world, despite such complex circumstances. As is the tradition of the magazine, we present a summary of the main essays presented during the congress:

- Early Rhythm-Control Therapy in Patients with Atrial Fibrillation (EAST-AFNET 4)

- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure (The EMPEROR-Reduced Trial Investigators)

- Efficacy and Safety of Mavacamten in Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy (EXPLORER-HCM)

- Angiotensin Receptor Neprilysin Inhibition Compared with Individualized Medical Therapy for Comorbidities in Patients with Heart Failure and Preserved Ejection Fraction (The PARALLAX Trial)

- A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients with Chronic Kidney Disease (DAPA-CKD)

- Aspirin with or without Clopidogrel after Transcatheter Aortic-Valve Implantation (POPULAR TAVI (Cohort A))

- Colchicine in Patients with Chronic Coronary Disease (The LoDoCo2 Trial Investigators)

- Pharmacological Blood Pressure-Lowering for Primary and Secondary Prevention of Cardiovascular Disease Across Different Levels of Blood Pressure (BPLTTC)

- Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (The BRACE CORONA Trial)

- Randomized Trial of Transfusion Strategies in Patients with Myocardial Infarction and Anemia (REALITY Trial)

Palabras clave : EAST-AFNET 4; EMPEROR; EXPLORER-HCM; PARALLAX; DAPA-CKD; POPULAR-TAVI; LODOCO2; BPLTTC; BRACE CORONA; REALITY.

        · resumen en Español | Portugués     · texto en Español     · Español ( pdf )